FIELD: biotechnology.
SUBSTANCE: invention relates to a method for reducing the amount of polypeptide transporting organic anions 1B1 (OATP1B1) in vitro. Said method involves culturing the human hepatocellular carcinoma cell line HepG2 in Dulbecco's modified Eagle's medium with glucose content of 4,500 mg/l, containing L-glutamine 4 mM, 15% bovine serum, 100 units/ml of penicillin and 100 mcg/ml of streptomycin, for 5 days, and adding progesterone to the medium to achieve its concentration in the medium selected from 10 and 100 mcM, followed by incubation for 24 hours.
EFFECT: present invention provides an accessible and cheap method of reducing the amount of OATP1B1 in an experiment in vitro.
1 cl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF INCREASING AMOUNT OF POLYPEPTIDE TRANSPORTING ORGANIC ANIONS 1B1 (OATP1B1) | 2024 |
|
RU2823925C1 |
METHOD FOR INCREASING BREAST CANCER RESISTANCE PROTEIN AMOUNT IN EXPERIMENT ON HUMAN HEPATOCELLULAR CARCINOMA CELL LINE | 2023 |
|
RU2803336C1 |
METHOD OF TESTING MEDICINAL SUBSTANCES FOR BELONGING TO SUBSTRATES OF POLYPEPTIDE TRANSPORTING ORGANIC ANIONS 1B1 | 2023 |
|
RU2815047C1 |
METHOD FOR INCREASING AMOUNT OF CONSTITUTIVE ANDROSTANE RECEPTOR | 2021 |
|
RU2755507C1 |
METHOD FOR INHIBITION OF GLYCOPROTEIN-P IN AN IN VITRO EXPERIMENT | 2021 |
|
RU2779177C1 |
METHOD FOR INCREASING QUANTITY OF CONSTIUTIVE ANDROSTANE RECEPTOR IN IN-VITRO EXPERIMENT | 2023 |
|
RU2812629C1 |
METHOD OF ABCB1 PROTEIN INHIBITION IN EXPERIMENT IN VITRO | 2023 |
|
RU2811993C1 |
METHOD FOR STIMULATING MYOGENESIS | 2021 |
|
RU2776045C1 |
METHOD FOR ACTIVATING THE MYOGENIC DIFFERENTIATION OF MYOBLASTS | 2021 |
|
RU2780589C1 |
METHOD OF INCREASING QUANTITY OF PREGNANE X RECEPTOR IN IN VITRO EXPERIMENT | 2023 |
|
RU2808299C1 |
Authors
Dates
2024-11-26—Published
2024-01-16—Filed